GSI 705 Pill - blue capsule/oblong, 18mm

Generic Name: emtricitabine/tenofovir disoproxil

Pill with imprint GSI 705 is Blue, Capsule/Oblong and has been identified as Truvada 167 mg / 250 mg. It is supplied by Gilead Sciences, Inc.

Truvada is used in the treatment of Pre-Exposure Prophylaxis of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 705

Generic Name: emtricitabine/tenofovir disoproxil
Imprint: GSI 705
Strength: 167 mg / 250 mg
Color: Blue
Size: 18.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Antiviral combinations
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: Gilead Sciences, Inc.
National Drug Code (NDC): 61958-0705
Inactive Ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch, water, FD&C Blue No. 2, aluminum oxide, titanium dioxide, triacetin
Note: Inactive ingredients may vary.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Drug Status

Availability Prescription only Rx

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug N/A

Approval History Drug history at FDA

User Reviews & Ratings

6.2 / 10